ONE Bio (ONBI) News Today $0.0030 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Zenas Bio: Recent IPO With Late-Stage CandidateOctober 22, 2024 | seekingalpha.comMillie Bobby Brown and Jake Bongiovi share wedding photos, including with Jon Bon JoviOctober 3, 2024 | usatoday.comOne-on-one with legendary coach Bobby KnightSeptember 29, 2024 | msn.comSponsored: Benefits of bio-identical hormone replacement therapySeptember 10, 2024 | msn.comSanyou Bio's Innovative Intelligent Antibody Design oneClick+ Platform is Officially LaunchedAugust 15, 2024 | tmcnet.comDay One Biopharma draws double upgrade at BofA on Ojemda potentialAugust 3, 2024 | msn.comBio-One Tampa CEO: Behind The Scenes Of Crime And Biohazard Clean-UpAugust 1, 2024 | msn.comStrong Buy Rating for Day One Biopharmaceuticals Amid Strategic Partnership and Promising Financial HealthJuly 26, 2024 | markets.businessinsider.comBeyond the bio: The evolution of link in bio and its role in shaping the creator economyJuly 19, 2024 | msn.comBiogen inks $1.8B deal to acquire immune drug developer HI-BioMay 22, 2024 | msn.comINmune Bio: An Opportunity In The Freefall (Rating Upgrade)April 22, 2024 | seekingalpha.comThe Best All-in-One ComputerApril 17, 2024 | nytimes.comSyntekabio to Showcase Innovative AI Drug Discovery Technologies at Bio-IT WorldApril 11, 2024 | tmcnet.comBenue: Prove Ortom Owns Pure Bio Tech Or Apologise To Him Now, Akase Challenges State GovtApril 6, 2024 | msn.comAnimal-free egg protein startup Onego Bio is one step closer to cracking the traditional egg marketApril 2, 2024 | techcrunch.comBoundless Bio Starts $100 Million U.S. IPO PlanMarch 13, 2024 | seekingalpha.comStartup Boundless Bio files to go public — San Diego's first life science IPO of 2024March 7, 2024 | msn.comBuy Rating Affirmed for Day One Biopharmaceuticals Amid Strong Pre-Launch Strategy and Solid FinancialsFebruary 27, 2024 | markets.businessinsider.comINmune Bio (INMB) Price Target Increased by 13.46% to 20.06February 25, 2024 | msn.comIntelligent Bio Solutions (INBS) Price Target Increased by 1100.00% to 113.83February 24, 2024 | msn.comOne Big Step for Bioelectronic Implant Developers Including US Nuclear’s Partner GraphetonFebruary 12, 2024 | markets.businessinsider.comBelfast bio-tech firm using AI to help cure cancer, awarded £1.4m in grant fundingFebruary 12, 2024 | msn.comStartups to Watch: Mercury Bio ready to scale biomolecular drug delivery platformFebruary 6, 2024 | bizjournals.comUPDATE 2-2seventy bio to sell experimental cell therapies, names new CEOJanuary 31, 2024 | msn.comThis Biotech Company Could Change the IVF Process for People Like Me With Low Ovarian ReserveJanuary 23, 2024 | msn.comIn 2024, Biosensors Are Becoming More Accessible: What It Means for YouJanuary 21, 2024 | msn.comIf You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 NamesJanuary 10, 2024 | msn.comProcept BioRobotics Shares Are Higher Today, CEO Touts 'Strong Surgeon Interest'January 9, 2024 | msn.comImbed Biosciences unwraps $10M convertible financingJanuary 8, 2024 | axios.comBayer-AskBio’s Parkinson’s gene therapy trial meets primary endpointJanuary 5, 2024 | msn.comPeninsula biotech raises $95 million to target diseases wreaking havoc on the immune systemJanuary 5, 2024 | bizjournals.comONE Bio Corp. (ONBI)December 28, 2023 | au.finance.yahoo.comBIO-key repays $2.2M senior secured noteDecember 21, 2023 | msn.comINmune Bio Shares Drop as Alzheimer's Treatment Study Remains on HoldDecember 19, 2023 | marketwatch.comBluebird bio, Rockwell Medical among healthcare moversDecember 8, 2023 | msn.comAbbVie to Buy Neuroscience Biotech Firm Cerevel for $8.7 BillionDecember 6, 2023 | msn.comOctarine Bio Raises $4.6M to Scale Bio-Based DyesDecember 4, 2023 | yahoo.comBioVie: Update Following Topline Results (Rating Downgrade)December 2, 2023 | seekingalpha.comMeet ‘anthrobots,’ tiny bio-machines built from human tracheal cellsNovember 30, 2023 | yahoo.comAnnovis Bio stock price jumps on positive news about experimental Alzheimer's disease therapyNovember 27, 2023 | bizjournals.comViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanomedicinesNovember 13, 2023 | markets.businessinsider.comDeep Bio and CancerX bring AI to cancer diagnostics and prognosisNovember 8, 2023 | msn.comKorean gov’t launches Bio-Health Innovation Commission to support AI and nanotech growthNovember 6, 2023 | msn.comBIO-key International Announces Closing of $3.75 Million Public OfferingOctober 31, 2023 | benzinga.comBIO-key International announces pricing of $3.75M public offeringOctober 30, 2023 | msn.comBIO-key International Announces Pricing of $3.75 Million Public OfferingOctober 30, 2023 | benzinga.comIntelligent Bio (NASDAQ: INBS) Announces New Zealand Expansion: Medical Stocks Growing Momentum" INBS, XTRX, CNXA, DNAOctober 24, 2023 | benzinga.comGeneration Bio Shares Fall to 52-Week Low After DNA UpdateOctober 19, 2023 | marketwatch.comIsraeli biotech startup mana.bio launches AI-fueled programmable drug therapyOctober 12, 2023 | techcrunch.com2seventy bio CEO out as company lays off 176September 12, 2023 | bizjournals.com Get ONE Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ONBI and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. ONBI Media Mentions By Week ONBI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONBI News Sentiment▼0.000.35▲Average Basic Materials News Sentiment ONBI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONBI Articles This Week▼00▲ONBI Articles Average Week Get ONE Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ONBI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Navidea Biopharmaceuticals News Propanc Biopharma News Hero Technologies News Wellness Center USA News Eagle Pharmaceuticals News Optec International News Parnell Pharmaceuticals News Comera Life Sciences News Statera Biopharma News Evelo Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ONBI) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ONE Bio Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share ONE Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
